Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.52 USD | -3.80% | 0.00% | -17.39% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
Financials (USD)
Sales 2024 * | 66.53M | Sales 2025 * | 80.63M | Capitalization | 173M |
---|---|---|---|---|---|
Net income 2024 * | -43M | Net income 2025 * | -37M | EV / Sales 2024 * | 2.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.14 x |
P/E ratio 2024 * |
-3.8
x | P/E ratio 2025 * |
-4.96
x | Employees | 217 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.05% |
Latest transcript on Biodesix, Inc.
1 day | -3.80% | ||
Current month | +22.58% | ||
1 month | +23.58% | ||
3 months | -3.80% | ||
6 months | +16.92% | ||
Current year | -17.39% |
Managers | Title | Age | Since |
---|---|---|---|
Scott Hutton
CEO | Chief Executive Officer | 52 | - |
Robin Cowie
DFI | Director of Finance/CFO | 44 | 11-02-28 |
James R. Jett
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Patience
CHM | Chairman | 76 | 08-05-31 |
Jack Schuler
BRD | Director/Board Member | 83 | 11-12-31 |
Jon Kayyem
BRD | Director/Board Member | 60 | 21-12-05 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 1.52 | -3.80% | 95,811 |
24-05-10 | 1.58 | +1.94% | 100,929 |
24-05-09 | 1.55 | 0.00% | 207,807 |
24-05-08 | 1.55 | 0.00% | 73,004 |
24-05-07 | 1.55 | +1.97% | 204,914 |
Delayed Quote Nasdaq, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.39% | 180M | |
-14.90% | 8.49B | |
+60.25% | 4.08B | |
-43.01% | 2.42B | |
-9.98% | 2.42B | |
-3.24% | 2.33B | |
-3.40% | 2.01B | |
-19.79% | 1.53B | |
-40.57% | 1.26B | |
+9.11% | 1.07B |
- Stock Market
- Equities
- BDSX Stock